While I am almost 100% skeptical of Garza's pump on biomedreports.com, I do find that ASTM will have a very good chance to demonstrate historical stem cell therapy first in CLI.The interim data (n=46) was significant. But the number of patients was… More
Lately, Aastrom has suffered from over-promising and under-delivering on the advanced clinical trials of their tissue repair cells. Did I say Aastrom suffered? I mean their shareholders suffered. Aastrom reverse split and raised more cash.Once again… More